Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Modern Surgical Techniques in Cytoreductive Surgery.

Izquierdo F, Sherman SK, Schuitevoerder D, Turaga KK.

J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04243-8. [Epub ahead of print] No abstract available.

PMID:
31197686
2.

It Is Time.

Turaga KK, Gamblin TC, Edwards R, Alexander HR, Bartlett D.

Ann Surg Oncol. 2019 Jul;26(7):1963-1966. doi: 10.1245/s10434-019-07207-z. Epub 2019 Apr 29. No abstract available.

PMID:
31037435
3.

Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer.

Eng OS, Turaga KK.

J Surg Oncol. 2019 Apr;119(5):613-615. doi: 10.1002/jso.25438. Epub 2019 Mar 10. Review.

PMID:
30852849
4.

Correction to: Peritoneal Metastases in Colorectal Cancer.

Jacobson R, Sherman SK, Dahdaleh F, Turaga KK.

Ann Surg Oncol. 2019 Jan 16. doi: 10.1245/s10434-019-07173-6. [Epub ahead of print]

PMID:
30652226
5.

Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KK.

JAMA Oncol. 2018 Nov 29. doi: 10.1001/jamaoncol.2018.5070. [Epub ahead of print]

PMID:
30489611
6.

Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial.

Dahdaleh FS, Sherman SK, Poli EC, Vigneswaran J, Polite BN, Sharma MR, Catenacci DV, Maron SB, Turaga KK.

Surgery. 2018 Dec;164(6):1223-1229. doi: 10.1016/j.surg.2018.06.044. Epub 2018 Oct 5.

PMID:
30297240
7.

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.

Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE.

J Clin Oncol. 2018 Oct 1;36(28):2863-2871. doi: 10.1200/JCO.2018.78.5204. Epub 2018 Aug 16.

PMID:
30113886
8.

Outcomes of Silicone Ahmed Glaucoma Valve Implantation in Refractory Pediatric Glaucoma.

Senthil S, Turaga K, Mohammed HA, Krishnamurthy R, Badakere S, Dikshit S, Choudhari N, Mandal AK, Garudadri CS.

J Glaucoma. 2018 Sep;27(9):769-775. doi: 10.1097/IJG.0000000000001032.

PMID:
30059405
9.

A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis.

Arjona-Sanchez A, Esquivel J, Glehen O, Passot G, Turaga KK, Labow D, Rufian-Peña S, Morales R, van der Speeten K.

Surg Endosc. 2019 Mar;33(3):854-860. doi: 10.1007/s00464-018-6352-4. Epub 2018 Jul 12.

PMID:
30003349
10.

Evolving Treatment Strategies and Outcomes in Advanced Gastric Cancer with Peritoneal Metastasis.

Dahdaleh FS, Turaga KK.

Surg Oncol Clin N Am. 2018 Jul;27(3):519-537. doi: 10.1016/j.soc.2018.02.006. Review.

PMID:
29935687
11.

Estimating Surgical Risk for Patients With Severe Comorbidities.

Sherman SK, Poli EC, Kapadia MR, Turaga KK.

JAMA Surg. 2018 Aug 1;153(8):778-780. doi: 10.1001/jamasurg.2018.1055. No abstract available.

PMID:
29847676
12.

Together We Make a Difference.

Turaga KK, Clark Gamblin T, Richard Alexander H, Edwards R, Bartlett DL.

Ann Surg Oncol. 2018 Jul;25(7):1794-1796. doi: 10.1245/s10434-018-6338-4. Epub 2018 May 15. No abstract available.

PMID:
29766390
13.

Peritoneal Metastases in Colorectal Cancer.

Jacobson R, Sherman SK, Dadaleh F, Turaga KK.

Ann Surg Oncol. 2018 Aug;25(8):2145-2151. doi: 10.1245/s10434-018-6490-x. Epub 2018 May 10. Review. No abstract available. Erratum in: Ann Surg Oncol. 2019 Jan 16;:.

PMID:
29748885
14.

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.

Pectasides E, Stachler MD, Derks S, Liu Y, Maron S, Islam M, Alpert L, Kwak H, Kindler H, Polite B, Sharma MR, Allen K, O'Day E, Lomnicki S, Maranto M, Kanteti R, Fitzpatrick C, Weber C, Setia N, Xiao SY, Hart J, Nagy RJ, Kim KM, Choi MG, Min BH, Nason KS, O'Keefe L, Watanabe M, Baba H, Lanman R, Agoston AT, Oh DJ, Dunford A, Thorner AR, Ducar MD, Wollison BM, Coleman HA, Ji Y, Posner MC, Roggin K, Turaga K, Chang P, Hogarth K, Siddiqui U, Gelrud A, Ha G, Freeman SS, Rhoades J, Reed S, Gydush G, Rotem D, Davison J, Imamura Y, Adalsteinsson V, Lee J, Bass AJ, Catenacci DV.

Cancer Discov. 2018 Jan;8(1):37-48. doi: 10.1158/2159-8290.CD-17-0395. Epub 2017 Oct 4.

15.

Bilateral normal tension glaucoma: Can this be nutritional?

Senthil S, Turaga K.

Indian J Ophthalmol. 2017 Jul;65(7):625-628. doi: 10.4103/ijo.IJO_794_16.

16.

Current management strategies for peritoneal mesothelioma.

Turaga KK, Deraco M, Alexander HR.

Int J Hyperthermia. 2017 Aug;33(5):579-581. doi: 10.1080/02656736.2017.1320591. Review.

PMID:
28664790
17.

Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer.

Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK.

Lancet Oncol. 2017 Jun;18(6):711-712. doi: 10.1016/S1470-2045(17)30336-4. No abstract available.

PMID:
28593843
18.

Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Morris RS, Gani F, Hammad AY, Peltier W, Gamblin TC, Turaga KK, Johnston FM.

J Surg Res. 2017 May 1;211:79-86. doi: 10.1016/j.jss.2016.11.066. Epub 2016 Dec 14.

PMID:
28501134
19.

Ushering in a New Era for Regional Therapies.

Turaga KK, Clark Gamblin T, Edwards R, Richard Alexander H, Bartlett DL.

Ann Surg Oncol. 2017 Apr;24(4):868-869. doi: 10.1245/s10434-017-5779-5. Epub 2017 Jan 26. No abstract available.

PMID:
28127651
20.

Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database.

Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston FM.

Ann Palliat Med. 2017 Jan;6(1):26-35. doi: 10.21037/apm.2016.11.02. Epub 2016 Nov 22.

21.

Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy.

Sugarbaker PH, Turaga KK, Alexander HR Jr, Deraco M, Hesdorffer M.

J Oncol Pract. 2016 Oct;12(10):928-935.

PMID:
27858561
22.

Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival.

Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christian KK, Johnston FM, Pawlik TM, Gamblin TC.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):912-920. Epub 2016 Sep 21.

PMID:
27654107
23.

Morbidity of curative cancer surgery and suicide risk.

Jayakrishnan TT, Sekigami Y, Rajeev R, Gamblin TC, Turaga KK.

Psychooncology. 2017 Nov;26(11):1792-1798. doi: 10.1002/pon.4221. Epub 2016 Aug 12.

PMID:
27421798
24.

Recurrent spontaneous scleral rupture in Marfan's syndrome.

Turaga K, Senthil S, Jalali S.

BMJ Case Rep. 2016 May 19;2016. pii: bcr2016214764. doi: 10.1136/bcr-2016-214764.

25.

Single-stage resection and microwave ablation for bilobar colorectal liver metastases.

Philips P, Groeschl RT, Hanna EM, Swan RZ, Turaga KK, Martinie JB, Iannitti DA, Schmidt C, Gamblin TC, Martin RC.

Br J Surg. 2016 Jul;103(8):1048-54. doi: 10.1002/bjs.10159. Epub 2016 May 18.

PMID:
27191368
26.

Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)?

Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga KK.

J Surg Oncol. 2016 Jun;113(7):823-7. doi: 10.1002/jso.24232. Epub 2016 Apr 6.

PMID:
27060344
27.

Hepatic Perfusion Therapy.

Rajeev R, Gamblin TC, Turaga KK.

Surg Clin North Am. 2016 Apr;96(2):357-68. doi: 10.1016/j.suc.2015.12.005. Review.

PMID:
27017869
28.
29.

Neoadjuvant radiotherapy for retroperitoneal sarcoma: A systematic review.

Cheng H, Miura JT, Lalehzari M, Rajeev R, Donahue AE, Bedi M, Gamblin TC, Turaga KK, Johnston FM.

J Surg Oncol. 2016 May;113(6):628-34. doi: 10.1002/jso.24221. Epub 2016 Mar 16. Review.

PMID:
26990903
30.

Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion.

Rajeev R, Klooster B, Turaga KK.

J Gastrointest Oncol. 2016 Feb;7(1):122-8. doi: 10.3978/j.issn.2078-6891.2015.099. Review.

31.

A literature review of radiological findings to guide the diagnosis of gallbladder adenomyomatosis.

Hammad AY, Miura JT, Turaga KK, Johnston FM, Hohenwalter MD, Gamblin TC.

HPB (Oxford). 2016 Feb;18(2):129-135. doi: 10.1016/j.hpb.2015.09.006. Epub 2016 Jan 6. Review.

32.

Cost Differential of Chemotherapy for Solid Tumors.

Nadeem H, Jayakrishnan TT, Rajeev R, Johnston FM, Gamblin TC, Turaga KK.

J Oncol Pract. 2016 Mar;12(3):e299-307, 251. doi: 10.1200/JOP.2015.006700. Epub 2016 Feb 9.

PMID:
26860586
33.

Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma.

Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK.

Ann Surg Oncol. 2016 Jul;23(7):2295-301. doi: 10.1245/s10434-016-5105-7. Epub 2016 Feb 8.

PMID:
26856719
34.

Uveitis-glaucoma-hyphaema syndrome with in-the-bag placement of intraocular lens.

Badakere SV, Senthil S, Turaga K, Garg P.

BMJ Case Rep. 2016 Jan 19;2016. pii: bcr2015213745. doi: 10.1136/bcr-2015-213745.

35.

Regional Therapies for Advanced Cancer: Update for 2016.

Turaga KK, Gamblin TC, Alexander HR, Edwards R, Bartlett DL.

Ann Surg Oncol. 2016 May;23(5):1452-3. doi: 10.1245/s10434-015-5068-0. Epub 2016 Jan 5. No abstract available.

PMID:
26732273
36.

Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma.

Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, Turaga KK.

Int J Clin Oncol. 2016 Jun;21(3):602-8. doi: 10.1007/s10147-015-0918-0. Epub 2015 Dec 8.

PMID:
26646222
37.

Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis.

Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK.

PLoS One. 2015 Oct 8;10(10):e0139940. doi: 10.1371/journal.pone.0139940. eCollection 2015.

38.

Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy.

Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC.

HPB (Oxford). 2015 Dec;17(12):1119-23. doi: 10.1111/hpb.12504. Epub 2015 Sep 16.

39.

Retroperitoneal solitary fibrous tumor: surgery as first line therapy.

Rajeev R, Patel M, Jayakrishnan TT, Johnston FM, Bedi M, Charlson J, Turaga KK.

Clin Sarcoma Res. 2015 Aug 27;5:19. doi: 10.1186/s13569-015-0034-y. eCollection 2015.

40.

Palliative Care Training in Surgical Oncology and Hepatobiliary Fellowships: A National Survey of Program Directors.

Larrieux G, Wachi BI, Miura JT, Turaga KK, Christians KK, Gamblin TC, Peltier WL, Weissman DE, Nattinger AB, Johnston FM.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1181-6. doi: 10.1245/s10434-015-4805-8. Epub 2015 Aug 18.

PMID:
26282906
41.

Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.

Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK.

Eur J Surg Oncol. 2015 Oct;41(10):1386-92. doi: 10.1016/j.ejso.2015.07.014. Epub 2015 Jul 29.

PMID:
26251340
42.

Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.

Miura JT, Johnston FM, Tsai S, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin TC.

HPB (Oxford). 2015 Oct;17(10):896-901. doi: 10.1111/hpb.12446. Epub 2015 Jul 31.

43.

Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines.

Marcus RK, Geurts JL, Grzybowski JA, Turaga KK, Clark Gamblin T, Strong KA, Johnston FM.

Fam Cancer. 2015 Dec;14(4):641-9. doi: 10.1007/s10689-015-9817-9.

PMID:
26108897
44.

Cost and Morbidity Analysis of Chest Port Insertion: Interventional Radiology Suite Versus Operating Room.

LaRoy JR, White SB, Jayakrishnan T, Dybul S, Ungerer D, Turaga K, Patel PJ.

J Am Coll Radiol. 2015 Jun;12(6):563-71. doi: 10.1016/j.jacr.2015.01.012.

45.

Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi-institutional analysis.

Tabrizian P, Jayakrishnan TT, Zacharias A, Aycart S, Johnston FM, Sarpel U, Labow DM, Turaga KK.

J Surg Oncol. 2015 Jun;111(8):1035-40. doi: 10.1002/jso.23924. Epub 2015 Jun 3.

PMID:
26040443
46.

Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers.

Glenn JA, Turaga KK, Gamblin TC, Hohmann SF, Johnston FM.

Surg Endosc. 2015 Dec;29(12):3768-75. doi: 10.1007/s00464-015-4152-7. Epub 2015 Mar 20.

PMID:
25791064
47.

Moving fast and moving slow.

Turaga KK, Clark Gamblin T, Richard Alexander H, Edwards R, Bartlett DL.

Ann Surg Oncol. 2015 May;22(5):1631-3. doi: 10.1245/s10434-015-4426-2. Epub 2015 Mar 18. No abstract available.

PMID:
25783677
48.

Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.

Miura JT, Xiu J, Thomas J, George B, Carron BR, Tsai S, Johnston FM, Turaga KK, Gamblin TC.

Cancer Biol Ther. 2015;16(5):764-9. doi: 10.1080/15384047.2015.1026479. Epub 2015 Mar 16.

49.

Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.

Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T.

Ann Surg Oncol. 2015 Oct;22(11):3716-23. doi: 10.1245/s10434-015-4501-8. Epub 2015 Mar 17.

PMID:
25777092
50.

Hepatectomy for hemangioma; safe, but is it successful?

Groeschl RT, Riggle KM, Quebbeman EJ, Christians KK, Turaga KK, Tsai S, Gamblin TC.

Hepatogastroenterology. 2014 Oct;61(135):2009-13.

PMID:
25713903

Supplemental Content

Loading ...
Support Center